Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-03-22

Clinical Trial Update: Lacosamide in Neonatal Status Epilepticus [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for lacosamide in neonatal status epilepticus; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lacosamide (Lacosamide)

Snippet

Sponsor: Sherief Abd-Elsalam | Conditions: Epilepsy | Phase 3 | Status: UNKNOWN